Y Intercept (Hong Kong) LTD Enanta Pharmaceuticals Inc Transaction History
Y Intercept (Hong Kong) LTD
- $1.78 Billion
- Q2 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 45,999 shares of ENTA stock, worth $481,609. This represents 0.03% of its overall portfolio holdings.
Number of Shares
45,999Holding current value
$481,609% of portfolio
0.03%Shares
4 transactions
Others Institutions Holding ENTA
# of Institutions
99Shares Held
21.2MCall Options Held
10.4KPut Options Held
2.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$21.9 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$20.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$19.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.46MShares$15.3 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.25MShares$13.1 Million7.45% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $217M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...